Delivery Order SPE2DB22D3501-SPE2DB24FWU07

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,049.48 firm fixed price delivery order contract to supply the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceuticals and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,324.85 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medication. The contract has a period of performance through May 14, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,291.24 contract is for the supply of WEGOVY 2.4 mg/0.75 mL pens to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,467.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical supply products to support military treatment programs and facilities under various...
The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. This $19,284.13 firm fixed price contract has a completion date of September 10, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities to support military treatment...
The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract valued at $3,371.19 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication, to support military healthcare programs. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, for the provision of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $46,077.36, has a period of performance through April 29, 2024 and utilizes a firm fixed price pricing structure. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp for $3,291.24 to supply the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and...
The Defense Logistics Agency (DLA) awarded a $6,465.69 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWU07
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $5,673.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 mg/0.75 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is intended to be completed by August 27, 2024. As a key supplier of pharmaceutical and medical products to various federal agencies, Amerisourcebergen leverages its extensive supply chain network to provide essential medications, supplies, and equipment to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/25/24, 9:15 AM